The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Atezolizumab (A) plus pertuzumab/trastuzumab/hyaluronidase (PHESGO) in patients (pts) with solid tumors with ERBB2 alterations (alt): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
 
Timothy Cannon
Honoraria - AstraZeneca; Revolution Medicines
 
Michael Rothe
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
No Relationships to Disclose
 
Andrew Gregory
No Relationships to Disclose
 
Meredith McKean
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Daiichi Sankyo (Inst); IDEAYA Biosciences (Inst); IQvia (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Pierre Fabre (Inst); Regeneron (Inst); Revolution Medicines (Inst)
Research Funding - Arcus Biosciences (Inst); Aulos Bioscience (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); BioNTech (Inst); Boehringer Ingelheim (Inst); C4 Therapeutics (Inst); Daiichi Sankyo (Inst); Dragonfly Therapeutics (Inst); Erasca, Inc (Inst); GenVivo (Inst); Gilead Sciences (Inst); IDEAYA Biosciences (Inst); Ikena Oncology (Inst); immatics (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Jazz Pharmaceuticals (Inst); Kezar Life Sciences (Inst); Krystal Biotech (Inst); Merck (Inst); Moderna Therapeutics (Inst); Nested Therapeutics (Inst); Novartis (Inst); NucMito Pharmaceuticals (Inst); OncoC4 (Inst); Pfizer (Inst); Pierre Fabre (Inst); Prelude Therapeutics (Inst); Regeneron (Inst); Repimune (Inst); Sapience Therapeutics (Inst); Synthorx (Inst); Teva (Inst); TScan Therapeutics (Inst)
 
Kunal Kadakia
No Relationships to Disclose
 
Evan Pisick
No Relationships to Disclose
 
Bamidele Adesunloye
Consulting or Advisory Role - Astellas Pharma; Eisai; Exelixis
 
Jasdeepa Nagi
No Relationships to Disclose
 
Erwin Grussie
No Relationships to Disclose
 
Carmen Calfa
No Relationships to Disclose
 
Majd Chahin
No Relationships to Disclose
 
Jaykumar Thumar
Stock and Other Ownership Interests - Merck Serono
Honoraria - Cardinal Health
Consulting or Advisory Role - Abbvie; AstraZeneca; Cardinal Health; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Cardinal Health
 
Stanley Nwabudike
No Relationships to Disclose
 
Gahyun Gim
Consulting or Advisory Role - Pfizer
 
Abigail Gregory
Employment - Pfizer (I)
Stock and Other Ownership Interests - Biohaven Pharmaceuticals (I); Pfizer (I)
Travel, Accommodations, Expenses - Pfizer (I)
 
Dominique Hinshaw
No Relationships to Disclose
 
Gina Grantham
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb; CG Oncology; J&J; Sanofi
 
Richard Schilsky
Leadership - Clarified Precision Medicine; Leap Therapeutics
Stock and Other Ownership Interests - Leap Therapeutics
Honoraria - Abbvie; Toray Industries; WUGEN, Inc.
Consulting or Advisory Role - Cellworks; Sygnomics; Zephyr AI
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Taiho Oncology (Inst)